Shyamali C Dharmage

From 🇱🇰| Living in 🇦🇺| She/Her | Redmond Barry Distinguished Professor and Head of Allergy and Lung Health Unit @ALHU_MSPGH @UniMelbMDHS @unimelbMSPGH

[Shyamali C Dharmage @CDharmage]

Honoured to be elected as a @AAHMS_health fellow last night. Thank you to all my mentors, collaborators and @ALHU_MSPGH for their important contributions to my career. @UniMelbMDHS @unimelbMSPGH

[Australian Academy of Health and Medical Sciences @AAHMS_health]

A leader in the life course of chronic lung diseases, she has changed global understanding of how lung disease #COPD originates, leading to new practices, policy and a new field of research, pre-COPD.
Welcome Distinguished Prof @Cdharmage as a new #AAHMSFellow. @UniMelbMDHS

[Shyamali C Dharmage @CDharmage]

Nice to see ABC coming together. We need more chronic lung diseases together to convince the importance of prevention of chronic lung disease to public, politicians and funders. Go ABC!!

[James D Chalmers @ProfJDChalmers]

You’ve heard of the A team
How about the ABC team??
Asthma, bronchiectasis and COPD coming together at GOLD2026 ❤️🫁
With my friends Alvar Agusti (GOLD) , Guy Brusselle (GINA) and @EMBARCnetwork

[Shyamali C Dharmage @CDharmage]

Proud and privileged to have the opportunity to contribute to the update of the Lancet COPD Commission, following my involvement in the first one. It is wonderful to continue being part of this important collective effort to advance COPD prevention, early detection, and care.

[ERS @EuroRespSoc]

Register now for ‘COPD can no longer wait – launch of the update of the Lancet Commission on COPD’ 🫁

This webinar, chaired by ERS President Dr Marc Miravitlles, will explore the recent second Lancet Commission on COPD. Learn more:
https://t.co/7waxb89cXE

[Francesca Polverino @FrancyPolverino]

COPD can no longer wait

Proud to have contributed to the updated @TheLancet Commission on COPD, launching November 11!

A global call to rethink how we prevent, diagnose, and treat COPD.

Join us for the launch hosted by @EuroRespSoc !
@LungAssociation @COPDFoundation @copd_inet @bcmhouston

🔗 https://t.co/8g3mJO81zL

[Respirology @RespirologyAPSR]

📣 EDITORS CHOICE:
Biomarkers of Pre-COPD Lung Function Trajectories in Middle Age: A Prospective Study From 1st to 6th Decade
🖋️ Dinh S. Bui, Don Vicendese, Jonathan Pham, et al.
https://t.co/uXNyZVlkP1

[Shyamali C Dharmage @CDharmage]

Nice editorial on the statistical models used in the study on biomarkers of pre-COPD lung function trajectories.

[Respirology @RespirologyAPSR]

🗨️ EDITORIAL: Heading in the Right Direction: Statistical Models for Lung Function Trajectories and Their Associations With Biomarkers
🖋️ Andrew Robert Gray
https://t.co/GBcX4I6ptc
on recent article:
https://t.co/uXNyZVlkP1

[Shyamali C Dharmage @CDharmage]

@FrancyPolverino @ATSBlueEditor @BCMFromtheLabs @BCMDeptMedicine @sucre_jen @copd_inet @COPDFoundation @AlanWaich4 Congratulations on excellent work

[Shyamali C Dharmage @CDharmage]

Another step towards identifying and treating those with progressive Pre-COPD. Great contribution by Tasmanian Logotudinal Health Study (TAHS)

[Respirology @RespirologyAPSR]

📣 NEW ARTICLE: Biomarkers of Pre-COPD Lung Function Trajectories in Middle Age: A Prospective Study From 1st to 6th Decade
#openaccess https://t.co/uXNyZVlkP1

[Shyamali C Dharmage @CDharmage]

Such a great editorial by Professors Licari and Corsico. The idea of "durable physiological signatures" is very useful for thinking about the impact of early events on later lung function.

[JiachengLiu @Jiacheng2899630]

We also appreciate the accompanying Comment from @LancetRespirMed on our FEF25–75% trajectory study. @CDharmage @ALHU_MSPGH

https://t.co/JDdgxIfHFn

[Shyamali C Dharmage @CDharmage]

Congratulations Jiachang on getting your last PhD paper in LRM. What a great paper to finish off your PhD - novel findings on MEF trajectories !!

[JiachengLiu @Jiacheng2899630]

Our study, based on data from TAHS, is now published in @LancetRespirMed. This study identified six FEF25-75% trajectories from age 7 to 53 years. Thanks to all co-authors for their insights and contributions. @CDharmage @ALHU_MSPGH

https://t.co/JOkgWlMCr2

[Shyamali C Dharmage @CDharmage]

@donsin4 Well done Rosa. Nice to see that the interest in pre-COPD is exponentially increasing. Let's keep the momentum going until we find interventions to arrest its progression to COPD.

[Shyamali C Dharmage @CDharmage]

I am honoured and humbled to have received this award. Thank you @nhmrc for supporting my research career over two and a half decades.

[NHMRC @nhmrc]

Recipient of the 2025 NHMRC Elizabeth Blackburn Investigator Grant Award for leadership in public health, @CDharmage has dedicated her research career to redefining COPD as a preventable life course condition, shifting the focus from late diagnosis to early intervention. Read more on Professor Dharmage’s career in her own words on our website: https://t.co/k61pM6evc6

[Shyamali C Dharmage @CDharmage]

Congratulations on a landmark paper, @ProfJDChalmers

[James D Chalmers @ProfJDChalmers]

A study 10 years in the making, just published in @LancetRespirMed
How do DPP1 inhibitors really work in bronchiectasis?
We show a novel mechanism for treatment efficacy, by inhibiting Azurocidin-1, a ciliotoxin, DPP1i can enhance mucociliary clearance.
https://t.co/eVR7fhgW7w

[Shyamali C Dharmage @CDharmage]

I am honoured and deeply humbled by Elizabeth Blackburn Award for Leadership in Public Health. Thank you @NHMRC for supporting my career and research for nearly 2.5 decades.

[NHMRC @nhmrc]

Congratulations to each of the 2025 Research Excellence Awardees honoured tonight for their success and thank you for sharing NHMRC’s vision of building a Healthy Australia. Read the full list of award winners on our website: https://t.co/hv2CkG9qxl

[Shyamali C Dharmage @CDharmage]

@ProfJDChalmers It was an inspiring presentation @ProfJDChalmers. You are such an excellent presenter too.

[Shyamali C Dharmage @CDharmage]

@ProfJDChalmers @LancetRespirMed Great paper !!

[James D Chalmers @ProfJDChalmers]

Our latest paper just out in @LancetRespirMed
10 unanswered questions about DPP1 inhibition in bronchiectasis

We outline key future clinical and research questions after the approval of the first new therapy for people with bronchiectasis.
Congratulations Jiahui, Chloe and @MereteLong

[Shyamali C Dharmage @CDharmage]

Honoured to be highlighted by @nhmrc . Thank you for supporting our research.

[NHMRC @nhmrc]

Chronic Obstructive Pulmonary Disease (COPD) is common and treatable but often diagnosed too late. NHMRC funded researcher Professor Shyamali Dharmage (@MDHS_UniMelb) is leading a world first trial of triple therapy to halt lung damage in pre-COPD #WorldCOPDDay

[Shyamali C Dharmage @CDharmage]

Stay tuned for Cure-Adire. Time that we put our resources together. Funded by MRFF, this project will commence in early 2026. As the lead, I like to thank all the PIs of respiratory studies for coming together for this grant application.

[Asthma Australia @AsthmaAustralia]

Professor Gary Anderson tells us about CURE ADIRE

[Asthma Australia @AsthmaAustralia]

Excited to learn about CURE-AIDRE which is a database of 75,000 asthma samples, decades in the making. It will be the engine to drive the search for treatments and cure. @CDharmage @tomiosifidis

[Shyamali C Dharmage @CDharmage]

@FrancyPolverino @EvaPolverino @EuroRespSoc @EMBARCnetwork ❤️